Clinical Edge Journal Scan

Adherence to CRC screening programs essential even in asymptomatic average-risk individuals


 

Key clinical point: The presence of some bowel symptoms increased the likelihood of being detected with colorectal cancer (CRC); however, 6 out of 10 participants diagnosed with CRC were asymptomatic. Rectal bleeding and change in bowel habits were associated with the detection of CRC.

Major finding: Almost 20.3% of participants screened with sigmoidoscopy had at least 1 symptom. However, almost 60% of individuals diagnosed with CRC were asymptomatic. Rectal bleeding (odds ratio [OR], 4.3; 95% confidence interval [CI], 3.1-6.1) and change in bowel habits (OR, 3.8; 95% CI, 2.4-6.1) were associated with the detection of CRC.

Study details: This was a cross-sectional study of 42,554 participants in the age group of 50-74 years who were invited to a randomized CRC screening trial for screening by either once-only sigmoidoscopy (n=36,059) or fecal immunochemical test (n=6,495).

Disclosures: The study was supported by grants from Norwegian Parliament. KR Randel declared receiving a research grant from the South-Eastern Norway Regional Health Authority. The other authors declared no conflicts of interest.

Source: Schult AL et al. BMJ Open. 2021 Jul 1. doi: 10.1136/bmjopen-2020-048183 .

Recommended Reading

NPs and PAs performing colonoscopies: Why not?
MDedge Hematology and Oncology
Performance matters in adenoma detection
MDedge Hematology and Oncology
Early-onset CRC associated with longer survival
MDedge Hematology and Oncology
Antibiotic linked to rise in early onset colon cancer?
MDedge Hematology and Oncology
Mutational signature may reveal underlying link between red meat and CRC
MDedge Hematology and Oncology
Good survival, outcomes with TARE for HCC in practice
MDedge Hematology and Oncology
Higher preoperative dietary fiber intake may reduce complications after CRC surgery
MDedge Hematology and Oncology
No benefit of adding pembrolizumab to neoadjuvant chemoradiotherapy in LARC
MDedge Hematology and Oncology
Survival correlates with response to preoperative chemotherapy in CRPM patients undergoing CRS/HIPEC
MDedge Hematology and Oncology
Efficacy of EGFR treatment for metastatic CRC differs with primary tumor location
MDedge Hematology and Oncology